Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|July 9, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis BPatrick Marcellin, Herve Mommeja-Marin, Stephen L Sacks, et al.
Journal of Hepatology|December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionMichael P Manns, Marc Bourlière, Yves Benhamou, et al.
Novartis Foundation Symposium|March 19, 2004
In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunityAlain P Vicari, Béatrice Vanbervliet, Catherine Massacrier, et al.
British Journal of Cancer|April 5, 2019
Sorafenib alone vs. sorafenib plus GEMOX as 1<sup>st</sup>-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trialEric Assenat, Georges-Philippe Pageaux, Simon Thézenas, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2024
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinomaClémentine Alitti, Agnès Rode, Hervé Trillaud, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|May 23, 2018
Recommendations for the use of electroencephalography and evoked potentials in comatose patientsNathalie André-Obadia, Julie Zyss, Martine Gavaret, et al.
Pageof 20